Clinical Trials Logo

Clinical Trial Summary

The LASH Contact Lens Study is a prospective longitudinal study of silicone hydrogel (SH) contact lens wearers who sleep in their lenses for up to 29 consecutive nights (30 days) of continuous wear (CW), with monthly disposal. Up to 207 healthy nearsighted or farsighted patients with minimal or no astigmatism and no contraindications to CW lens use will be followed for 1 year. The primary outcome measure is the time to development of a corneal inflammatory event (CIE) as defined by slit lamp findings and patient symptoms. The main exposure of interest is corneal staining. Other key exploratory variables include bacterial contamination of study lenses and inflammatory mediators found in the tear film.


Clinical Trial Description

n/a


Study Design

Observational Model: Cohort, Time Perspective: Prospective


Related Conditions & MeSH terms


NCT number NCT00727402
Study type Observational
Source National Eye Institute (NEI)
Contact
Status Completed
Phase N/A
Start date October 2006
Completion date October 2009

See also
  Status Clinical Trial Phase
Completed NCT01753583 - High-resolution Imaging of Corneal Lesions With Optical Coherence Tomography (OCT) - A Pilot Study N/A
Terminated NCT00579020 - A Phase II Study of Moxidex Ophthalmic Solution for Treatment of Marginal Corneal Infiltrates Phase 2